This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Headquartered in Los Angeles, CBRE Group, Inc., is a commercial real estate services and investment firm, offering a wide range of services to tenants, owners, lenders and investors in office, retail, industrial, multi-family and other types of commercial real estates in all major metropolitan areas across the globe. The services include valuation, real estate investment management, commercial property and corporate facilities management, tenant representation, occupier and property/agency leasing, property sales, commercial mortgage origination and servicing, capital markets (equity and debt) solutions, development services and proprietary research.
Zacks.com featured highlights include: O'Reilly Automotive, CBRE Group, Lithia Motors, The Interpublic Group of Companies and Aflac
by Zacks Equity Research
Zacks.com featured highlights include: O'Reilly Automotive, CBRE Group, Lithia Motors, The Interpublic Group of Companies and Aflac
5 Stocks That Flaunt an Impressive Interest Coverage Ratio
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. O'Reilly Automotive (ORLY), CBRE Group (CBRE), Lithia Motors (LAD), The Interpublic Group (IPG) and Aflac (AFL) are strong enough to meet financial obligations.
What's in the Cards for Realty Income's (O) Q3 Earnings?
by Zacks Equity Research
Realty Income's (O) Q3 results will likely reflect the benefits of having essential retail tenants in its roster and gains from accretive buyouts.
What's in Store for Federal Realty (FRT) This Earnings Season?
by Zacks Equity Research
Federal Realty's (FRT) Q3 results likely to reflect the gains from continued demand recovery from the global health crisis.
Here's How Regency (REG) is Placed Ahead of Q3 Earnings
by Zacks Equity Research
Regency's (REG) Q3 performance is likely to have gained from its premium retail properties in solid trade areas and a continued demand recovery.
Zacks.com featured highlights include: Seagate Technology, Best Buy, Celanese, CBRE Group and Regeneron Pharma
by Zacks Equity Research
Zacks.com featured highlights include: Seagate Technology, Best Buy, Celanese, CBRE Group and Regeneron Pharma
Here's How Simon Property (SPG) is Placed Ahead of Q3 Earnings
by Zacks Equity Research
Simon Property's (SPG) Q3 results likely to reflect the gains from continued demand recovery from the global health crisis.
CBRE Group (CBRE) Q3 Earnings & Revenues Beat Estimates
by Zacks Equity Research
CBRE Group's (CBRE) Q3 results reflect the benefits of diversifying and expanding its resilient business in recent years.
Top 5 High ROE Stocks to Buy as Fed Tapering Looms Large
by Supriyo Bose
Seagate Technology (STX), Best Buy (BBY), Celanese Corporation (CE), CBRE Group (CBRE), and Regeneron Pharmaceuticals (REGN) are some stocks with high ROE to buy as the Fed tapering decision is expected soon.
CBRE Group (CBRE) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
CBRE (CBRE) delivered earnings and revenue surprises of 15.83% and 1.43%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Why CBRE Group (CBRE) is a Top Stock for the Long-Term
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Why Earnings Season Could Be Great for CBRE Group (CBRE)
by Zacks Equity Research
CBRE Group (CBRE) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Here is Why Growth Investors Should Buy CBRE (CBRE) Now
by Zacks Equity Research
CBRE (CBRE) is well positioned to outperform the market, as it exhibits above-average growth in financials.
What's in the Offing for Realogy Holdings' (RLGY) Q3 Earnings?
by Zacks Equity Research
Realogy Holdings' (RLGY) Q3 results will likely reflect the benefits from its diverse brand portfolio and healthy transaction volumes.
What's in the Offing for CBRE Group's (CBRE) Q3 Earnings?
by Zacks Equity Research
CBRE Group's (CBRE) Q3 results will likely reflect benefits from its broad diversification across property types, lines of business, geographic markets and clients, and disciplined expense management.
Why CBRE (CBRE) Could Beat Earnings Estimates Again
by Zacks Equity Research
CBRE (CBRE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
CBRE (CBRE) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
CBRE (CBRE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here's How Much a $1000 Investment in CBRE Group Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
CBRE Group (CBRE) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
CBRE (CBRE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include: T. Rowe Price, Best Buy, Celanese Corp, CBRE Group and Regeneron Pharma
by Zacks Equity Research
Zacks.com featured highlights include: T. Rowe Price, Best Buy, Celanese Corp, CBRE Group and Regeneron Pharma
5 High ROE Stocks to Buy as Markets Face Intense Volatility
by Supriyo Bose
T. Rowe Price Group (TROW), Best Buy (BBY), Celanese Corporation (CE), CBRE Group (CBRE), and Regeneron Pharmaceuticals (REGN) are some of the stocks with high ROE to buy in a volatile market.
Rexford (REXR) Enhances Portfolio, Buyouts Reach $1.3B in '21
by Zacks Equity Research
The acquisitions of industrial properties in the prime in-fill Southern California markets will aid Rexford (REXR) to benefit from the healthy market fundamentals.
Why This 1 Finance Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
5 Stocks With High ROE as Markets Await Fed Tapering Outlook
by Supriyo Bose
OneMain Holdings (OMF), KLA Corporation (KLAC), Bunge Limited (BG), CBRE Group, (CBRE) and Regeneron Pharmaceuticals (REGN) are some of the stocks with high ROE to buy as markets await Fed tapering clarity.
Rexford (REXR) Boosts Portfolio, Acquisitions Reach $1.03B in 2021
by Zacks Equity Research
The acquisition of industrial properties in the prime in-fill Southern California markets will aid Rexford (REXR) to benefit from the healthy market fundamentals.